These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 19433562)
1. NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans. Pannu J; McCarthy A; Martin A; Hamouda T; Ciotti S; Fothergill A; Sutcliffe J Antimicrob Agents Chemother; 2009 Aug; 53(8):3273-9. PubMed ID: 19433562 [TBL] [Abstract][Full Text] [Related]
2. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology. Croxtall JD; Plosker GL Drugs; 2009; 69(3):339-59. PubMed ID: 19275277 [TBL] [Abstract][Full Text] [Related]
3. A new acridone with antifungal properties against Candida spp. and dermatophytes, and antibiofilm activity against C. albicans. de Oliveira DBC; Silva LB; da Silva BV; Borges TC; Marques BC; Dos Santos MB; de Oliveira LF; Bolzani VS; Rodrigues ARA; Regasini LO; Andrade AA J Appl Microbiol; 2019 Nov; 127(5):1362-1372. PubMed ID: 31297951 [TBL] [Abstract][Full Text] [Related]
4. Antifungal activity of phlorotannins against dermatophytes and yeasts: approaches to the mechanism of action and influence on Candida albicans virulence factor. Lopes G; Pinto E; Andrade PB; Valentão P PLoS One; 2013; 8(8):e72203. PubMed ID: 23951297 [TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Gupta AK; Kohli Y Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235 [TBL] [Abstract][Full Text] [Related]
6. The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi. Myc A; Vanhecke T; Landers JJ; Hamouda T; Baker JR Mycopathologia; 2002; 155(4):195-201. PubMed ID: 12650595 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of seven azole compounds against some clinical isolates of non-dermatophytic filamentous fungi and some dermatophytes. Oyeka CA; Gugnani HC Mycopathologia; 1990 Jun; 110(3):157-61. PubMed ID: 2388682 [TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes. Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461 [TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal activity of Polyporaceae against yeasts and dermatophytes. Steinmetz MD; Rascol JP; Régli P; Gargadennec A; Andary C Mycoses; 1995; 38(7-8):305-9. PubMed ID: 8559195 [TBL] [Abstract][Full Text] [Related]
10. An evaluation of the in vitro activity of terbinafine. Jessup CJ; Ryder NS; Ghannoum MA Med Mycol; 2000 Apr; 38(2):155-9. PubMed ID: 10817232 [TBL] [Abstract][Full Text] [Related]
11. Antifungal activities of seven West African Combretaceae used in traditional medicine. Baba-Moussa F; Akpagana K; Bouchet P J Ethnopharmacol; 1999 Sep; 66(3):335-8. PubMed ID: 10473181 [TBL] [Abstract][Full Text] [Related]
12. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Gupta AK; Kohli Y; Batra R Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561 [TBL] [Abstract][Full Text] [Related]
13. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method. Bhatia VK; Sharma PC Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960 [TBL] [Abstract][Full Text] [Related]
14. IN VITRO ANTIFUNGAL ACTIVITY OF 2,4-DIHYDROXY-N-(3-THIOXO-3H- 1,2,4-DITHIAZOL-5-YL)BENZENECARBOTHIOAMIDE. Lukaszuk C; Krajewska-Kulak E; Niewiadomy A; Szynaka B Acta Pol Pharm; 2016 Nov; 73(6):1511-1519. PubMed ID: 29634105 [TBL] [Abstract][Full Text] [Related]
15. A chemically modified tetracycline (CMT-3) is a new antifungal agent. Liu Y; Ryan ME; Lee HM; Simon S; Tortora G; Lauzon C; Leung MK; Golub LM Antimicrob Agents Chemother; 2002 May; 46(5):1447-54. PubMed ID: 11959581 [TBL] [Abstract][Full Text] [Related]
16. Antifungal Activity of Nontoxic Nanocomposite Based on Silver and Reduced Graphene Oxide against Dermatophytes and Gottardo B; Zoccal ARM; Maschio-Lima T; Lemes TH; Paziani MH; Von Zeska Kress MR; Perfecto TM; Almeida MTG; Volanti DP ACS Biomater Sci Eng; 2023 Dec; 9(12):6870-6879. PubMed ID: 37943794 [TBL] [Abstract][Full Text] [Related]
17. Nimesulide inhibits pathogenic fungi: PGE2-dependent mechanisms. de Matos RF; Mendonça LCV; da Silva Souza KG; Fonseca AAD; Costa EMS; de Lima MVD; Vieira JMDS; de Brito MTFM; Monteiro MC Folia Microbiol (Praha); 2017 Mar; 62(2):169-174. PubMed ID: 27866353 [TBL] [Abstract][Full Text] [Related]
18. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949 [TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan. Chadeganipour M; Nilipour S; Havaei A Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457 [TBL] [Abstract][Full Text] [Related]